Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2935 SEK | +1.21% | -2.17% | -27.98% |
Mar. 26 | Transcript : Vivesto AB - Special Call | |
Mar. 07 | Vivesto AB Doses First Patient in its Clinical Paccal Vet Trial | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.98% | 14.59M | |
+34.35% | 705B | |
+30.96% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.89% | 238B | |
-3.64% | 210B | |
+10.05% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- VIVE Stock
- News Vivesto AB
- Transcript : Oasmia Pharmaceutical AB, Q3 2021 Earnings Call, Nov 18, 2021